Latest News and Press Releases
Want to stay updated on the latest news?
-
PHILADELPHIA, May 06, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs...
-
Former Edgewise and Merck leader brings more than 15 years’ experience to guide Immutrin’s clinical strategy as the Company advances towards first-in-human studies Cambridge, UK, 6th May 2026Immutrin...
-
Payer coverage for TONMYA
-
Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates
First-quarter 2026 Rezdiffra® (resmetirom) net sales of $311.3 million, representing year-over-year growth of 127%As of March 31, 2026, more than 42,250 patients on Rezdiffra, up 2.5x from 1Q25,...
-
Former Edgewise and Merck leader brings more than 15 years’ experience to guide Immutrin’s clinical strategy as the Company advances towards first-in-human studies Cambridge, UK, 6th May 2026Immutrin...
-
Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance
-
Paris, France, Cambridge, USA, May 5th, 2026 – TISSIUM, a Medical Technology company pioneering biomorphic programmable polymers for tissue reconstruction, announced today it has appointed Marc...
-
Ingram Micro, Vertosoft, Liquid PC, and QBS partner with Huntress to scale global cyber defenses through their reseller ecosystems
-
Overall, studies show: OGM Can Resolve Previously Unresolved Rare Disease CasesOGM Can Serve as a Gold Standard Technique for Characterization of SVs OGM Can Complement Sequencing for Better SV...
-
Company advances its leadership in MASH with clinical-stage, genetically targeted siRNA asset from Arrowhead PharmaceuticalsPrecision approach targets patients who have a mutation in the PNPLA3 gene,...